{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:22:54Z","timestamp":1792131774007,"version":"4.4.0"},"reference-count":50,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100015223","name":"Danish Diabetes and Endocrine Academy","doi-asserted-by":"publisher","award":["NNF22SA0079901"],"award-info":[{"award-number":["NNF22SA0079901"]}],"id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The naturally occurring peptide, liver-expressed antimicrobial peptide 2 (LEAP2), has gained interest as a ghrelin receptor antagonist. We previously reported reduced food intake and plasma glucose\u2013lowering effects of LEAP2 infusion in lean healthy men; however, the effects of this competitive antagonist and inverse agonist of the ghrelin receptor in men with obesity have not been investigated. In the current study, 20 men with obesity were enrolled in a randomized, double-blind, placebo-controlled, crossover study comprising two experimental visits, each involving a \u223c5-h intravenous infusion of LEAP2 (infusion rate 40 pmol\/kg\/min) or placebo during which a liquid mixed meal test and a subsequent ad libitum meal test were performed. The LEAP2 infusion resulted in a fivefold increase in plasma concentrations of LEAP2 compared with placebo. The infusion lowered postprandial plasma glucose levels and reduced ad libitum food intake by \u223c12%. We conclude that a continuous intravenous LEAP2 infusion reduces glycemia and food intake in men with obesity, supporting further exploration of LEAP2\u2019s therapeutic potential in obesity and related metabolic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Liver-expressed antimicrobial peptide 2 (LEAP2), a ghrelin receptor antagonist and inverse agonist, reduces food intake and improves markers of dysmetabolism in preclinical studies and in lean men; however, the effects of LEAP2 in obesity are unknown. We investigated the effects of exogenous LEAP2 on ad libitum food intake and metabolic parameters in men with obesity. We found that LEAP2 reduces ad libitum food intake and reduces postprandial plasma glucose concentration, revitalizing the ghrelin receptor as a potential target in the treatment of obesity and its related conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-1132","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:54:12Z","timestamp":1774893252000},"page":"925-937","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":7,"title":["LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With Obesity"],"prefix":"10.2337","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2954-7260","authenticated-orcid":false,"given":"Anders","family":"Englund","sequence":"first","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen 1 , Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3620-2710","authenticated-orcid":false,"given":"Andreas H.","family":"Lange","sequence":"additional","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen 1 , Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer A.","family":"Hagemann","sequence":"additional","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen 1 , Hellerup, Denmark"},{"name":"Novo Nordisk A\/S, Bagsv\u00e6rd 2 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcs\u00fcn S.","family":"Kizilkaya","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen 3 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen 3 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-2036","authenticated-orcid":false,"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen 3 , Copenhagen, Denmark"},{"name":"Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen 4 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-3805","authenticated-orcid":false,"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen 3 , Copenhagen, Denmark"},{"name":"Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen 4 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9970-9535","authenticated-orcid":false,"given":"Flemming","family":"Dela","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen 3 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-3764","authenticated-orcid":false,"given":"Asger B.","family":"Lund","sequence":"additional","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen 1 , Hellerup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen 5 , Copenhagen, Denmark"},{"name":"Steno Diabetes Center Copenhagen 6 , Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-8515","authenticated-orcid":false,"given":"L\u00e6rke S.","family":"Gasbjerg","sequence":"additional","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen 1 , Hellerup, Denmark"},{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen 3 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-5034","authenticated-orcid":false,"given":"Filip K.","family":"Knop","sequence":"additional","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen 1 , Hellerup, Denmark"},{"name":"Novo Nordisk A\/S, Bagsv\u00e6rd 2 , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen 5 , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2026061712471855200_B1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/dom.14270","article-title":"An overview of obesity mechanisms in humans: endocrine regulation of food intake, eating behaviour and common determinants of body weight","volume":"23","author":"Theilade","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2026061712471855200_B2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2026061712471855200_B3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s42255-023-00812-z","article-title":"Gut hormone co-agonists for the treatment of obesity: from bench to bedside","volume":"5","author":"Nogueiras","year":"2023","journal-title":"Nat Metab"},{"key":"2026061712471855200_B4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0029-1233462","article-title":"Expression of ghrelin and its receptor in human tissues","volume":"41","author":"Ueberberg","year":"2009","journal-title":"Horm Metab Res"},{"key":"2026061712471855200_B5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"key":"2026061712471855200_B6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller","year":"2015","journal-title":"Mol Metab"},{"key":"2026061712471855200_B7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"2026061712471855200_B8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tsch\u00f6p","year":"2001","journal-title":"Diabetes"},{"key":"2026061712471855200_B9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2017.10.016","article-title":"LEAP2 is an endogenous antagonist of the ghrelin receptor","volume":"27","author":"Ge","year":"2018","journal-title":"Cell Metab"},{"key":"2026061712471855200_B10","doi-asserted-by":"crossref","first-page":"171227","DOI":"10.1016\/j.peptides.2024.171227","article-title":"Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans","volume":"177","author":"Englund","year":"2024","journal-title":"Peptides (NY)"},{"key":"2026061712471855200_B11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/acs.jmedchem.8b01644","article-title":"N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor","volume":"62","author":"M\u2019Kadmi","year":"2019","journal-title":"J Med Chem"},{"key":"2026061712471855200_B12","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1172\/JCI125332","article-title":"LEAP2 changes with body mass and food intake in humans and mice","volume":"129","author":"Mani","year":"2019","journal-title":"J Clin Invest"},{"key":"2026061712471855200_B13","doi-asserted-by":"crossref","first-page":"bvae214","DOI":"10.1210\/jendso\/bvae214","article-title":"Satiety hormone LEAP2 after low-calorie diet with\/without endobarrier insertion in obesity and type 2 diabetes mellitus","volume":"9","author":"Emini","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026061712471855200_B14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.122.001322","article-title":"A novel truncated liver enriched antimicrobial peptide-2 palmitoylated at its N-terminal antagonizes effects of ghrelin","volume":"383","author":"Hol\u00e1","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"2026061712471855200_B15","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.molmet.2024.101950","article-title":"A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice","volume":"84","author":"Shankar","year":"2024","journal-title":"Mol Metab"},{"key":"2026061712471855200_B16","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s40618-024-02307-4","article-title":"The effects of ghrelin and LEAP-2 in energy homeostasis are modulated by thermoneutrality, high-fat diet and aging","volume":"47","author":"Casado","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"2026061712471855200_B17","doi-asserted-by":"crossref","first-page":"100582","DOI":"10.1016\/j.xcrm.2022.100582","article-title":"LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men","volume":"3","author":"Hagemann","year":"2022","journal-title":"Cell Rep Med"},{"key":"2026061712471855200_B18","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/db24-1056","article-title":"Sustained weight loss with combined leap2 and semaglutide treatment in mice","volume":"74","author":"Holm","year":"2025","journal-title":"Diabetes"},{"key":"2026061712471855200_B19","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41467-020-18885-9","article-title":"Leptin alters energy intake and fat mass but not energy expenditure in lean subjects","volume":"11","author":"Chrysafi","year":"2020","journal-title":"Nat Commun"},{"key":"2026061712471855200_B20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","article-title":"Leptin in leanness and obesity","volume":"77","author":"Perakakis","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026061712471855200_B21","first-page":"3","volume-title":"Methods Neurosci","author":"Holst","year":"1991"},{"key":"2026061712471855200_B22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nmeth0405-319","article-title":"Calcium phosphate\u2013mediated transfection of eukaryotic cells","volume":"2","author":"Kumar","year":"2005","journal-title":"Nat Methods"},{"key":"2026061712471855200_B23","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ajcn\/87.5.1277","article-title":"Reproducibility and power of ad libitum energy intake assessed by repeated single meals","volume":"87","author":"Gregersen","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"2026061712471855200_B24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/00365520701370922","article-title":"Gastric emptying: a comparison of three methods","volume":"42","author":"Glerup","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"2026061712471855200_B25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF03343763","article-title":"Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans","volume":"23","author":"Arvat","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"2026061712471855200_B26","doi-asserted-by":"crossref","first-page":"bqaf011","DOI":"10.1210\/endocr\/bqaf011","article-title":"Critical insights into LEAP2 biology and physiological functions: potential roles beyond ghrelin antagonism","volume":"166","author":"Perell\u00f3","year":"2025","journal-title":"Endocrinology"},{"key":"2026061712471855200_B27","doi-asserted-by":"crossref","first-page":"e966","DOI":"10.1210\/clinem\/dgaa803","article-title":"Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment","volume":"106","author":"Hagemann","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061712471855200_B28","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2005-2638","article-title":"Ghrelin stimulates gastric emptying and hunger in normal-weight humans","volume":"91","author":"Levin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061712471855200_B29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ijo.2008.270","article-title":"Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects","volume":"33","author":"Huda","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"2026061712471855200_B30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"2026061712471855200_B31","doi-asserted-by":"crossref","first-page":"R547","DOI":"10.1152\/ajpregu.00232.2022","article-title":"Hindbrain ghrelin and liver-expressed antimicrobial peptide 2, ligands for growth hormone secretagogue receptor, bidirectionally control food intake","volume":"324","author":"Wald","year":"2023","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026061712471855200_B32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/cells11030324","article-title":"LEAP-2 counteracts ghrelin-induced food intake in a nutrient, growth hormone and age independent manner","volume":"11","author":"Lugilde","year":"2022","journal-title":"Cells"},{"key":"2026061712471855200_B33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.33549\/physiolres.935189","article-title":"High-fat diet induces resistance to ghrelin and LEAP2 peptide analogs in mice","volume":"72","author":"Hol\u00e1","year":"2023","journal-title":"Physiol Res"},{"key":"2026061712471855200_B34","doi-asserted-by":"crossref","first-page":"110573","DOI":"10.1016\/j.mce.2019.110573","article-title":"Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region","volume":"498","author":"Barrile","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"2026061712471855200_B35","doi-asserted-by":"crossref","first-page":"170763","DOI":"10.1016\/j.peptides.2022.170763","article-title":"Liver-expressed antimicrobial peptide 2 functions independently of growth hormone secretagogue receptor in calorie-restricted mice","volume":"151","author":"Islam","year":"2022","journal-title":"Peptides (NY)"},{"key":"2026061712471855200_B36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/JOE-19-0102","article-title":"Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents","volume":"244","author":"Islam","year":"2020","journal-title":"J Endocrinol"},{"key":"2026061712471855200_B37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.20823","article-title":"Expression of ghrelin receptor mRNA in the rat and the mouse brain","volume":"494","author":"Zigman","year":"2006","journal-title":"J Comp Neurol"},{"key":"2026061712471855200_B38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tips.2004.01.010","article-title":"Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation","volume":"25","author":"Holst","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"2026061712471855200_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.932761","article-title":"Involvement of POMC neurons in LEAP2 regulation of food intake and body weight","volume":"13","author":"Chu","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026061712471855200_B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-022-04302-5","article-title":"GHSR controls food deprivation-induced activation of CRF neurons of the hypothalamic paraventricular nucleus in a LEAP2-dependent manner","volume":"79","author":"Fernandez","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"2026061712471855200_B41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molmet.2016.04.007","article-title":"Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets","volume":"5","author":"DiGruccio","year":"2016","journal-title":"Mol Metab"},{"key":"2026061712471855200_B42","first-page":"S211","article-title":"Ghrelin and LEAP2 affect insulin and glucagon secretion in mouse, but not in human islets, and their effects in mouse islets are mediated by somatostatin","volume":"67","author":"Murdasov","year":"2024","journal-title":"Diabetologia"},{"key":"2026061712471855200_B43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molmet.2013.10.001","article-title":"Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of ghrelin","volume":"3","author":"Wang","year":"2014","journal-title":"Mol Metab"},{"key":"2026061712471855200_B44","first-page":"1169","article-title":"Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone","volume":"86","author":"Arvat","year":"2001"},{"key":"2026061712471855200_B45","doi-asserted-by":"crossref","first-page":"e44089","DOI":"10.1371\/journal.pone.0044089","article-title":"Hindbrain ghrelin receptor signaling is sufficient to maintain fasting glucose","volume":"7","author":"Scott","year":"2012","journal-title":"PLoS One"},{"key":"2026061712471855200_B46","doi-asserted-by":"crossref","first-page":"101996","DOI":"10.1016\/j.xcrm.2025.101996","article-title":"Regulation of LEAP2 by insulin and glucagon in mice and humans","volume":"6","author":"Johansen","year":"2025","journal-title":"Cell Rep Med"},{"key":"2026061712471855200_B47","first-page":"E981","article-title":"Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans","volume":"273","author":"Nauck","year":"1997","journal-title":"Am J Physiol"},{"key":"2026061712471855200_B48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1152\/ajpgi.00321.2007","article-title":"Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure","volume":"294","author":"Pfluger","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026061712471855200_B49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.regpep.2009.11.010","article-title":"Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats","volume":"160","author":"Mano-Otagiri","year":"2010","journal-title":"Regul Pept"},{"key":"2026061712471855200_B50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12916-023-03151-8","article-title":"Why diversity among participants in clinical studies is not always preferable: the case for small, exploratory studies","volume":"21","author":"Ellegaard","year":"2023","journal-title":"BMC Med"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/6\/925\/860638\/db251132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/6\/925\/860638\/db251132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:47:30Z","timestamp":1781714850000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/6\/925\/164645\/LEAP2-Reduces-Ad-Libitum-Food-Intake-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-1132","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}